News

NULL

The doctoral program also placed #7 in Chemistry in the publication’s latest issue ranking top science graduate schools.

Kiani brings decades of experience in patient safety and public service.

The recognized researchers encompass various areas including chemistry, microbiology, immunology, biochemistry and more.

Finance and biomedical leaders bring decades of experience in investment strategy and drug development.

The ceremony represented the largest graduating class since the doctoral program’s inception in 1989.

Chi-Huey Wong Laboratories for Biomedical Research recognized for sustainable construction.

Scripps Research announces its 2024 recipients of Collaborative Innovation Fund grants.

Scripps Research has added Benjamin Cravatt, PhD, professor of Chemistry and the Norton B. Gilula Chair in Biology and Chemistry at Scripps Research, and Lou Lange, MD, PhD, physician-scientist and general partner with Asset Management Ventures, to its Board of Directors.

Featured scientists represent a wide range of fields including chemistry, microbiology, immunology, neuroscience and more

The awards from the NIDDK and the LLHF will let Droujinine uncover how interorgan communication goes awry in metabolic disease and aging, paving the way for new treatments.

Scripps Research scientists discovered a molecule produced by roundworm intestines that signals the brain to slow fat loss when food is not available. 

The newly appointed faculty are making transformative discoveries in areas ranging across drug discovery, neuroscience, chemistry, immunity and more.

Scripps Research has appointed Professor Keary Engle to the role of Dean of Graduate and Postdoctoral Studies, effective July 1, 2024, and will lead the institute's Skaggs Graduate School of Chemical and Biological Sciences and other education and training programs.

Scripps Research’s vision to translate basic scientific discovery into effective treatments that benefit human health strikes a chord with Barbara Kosacz, JD—making her addition to the institution’s Board of Directors fitting.

Skaggs family also honored at commencement ceremony as first recipients of Scripps Research Presidential Medal

New Scripps Research trial aims to validate the use of wearables in guiding participants to effectively monitor mental, physical and emotional exertion—a strategy called pacing.

Calibr-Skaggs to partner with AbbVie to support discovery of next-generation sCAR-Ts using genetic medicine-based approaches.

The ALSAM Foundation, founded by the Skaggs family, provides lasting gift to Scripps Research’s drug discovery and development arm.

Long-acting combination HIV regimens have the potential to transform the future of coordinated HIV clinical care.  A Phase 1 trial has been initiated to evaluate GS-1614 - a novel prodrug of a nucleoside reverse transcriptase translocation inhibitor (NRTTI).

For the last century, institute leaders and renowned scientists have made Scripps Research what it is today: the world’s leading independent and nonprofit biomedical research institute at the forefront of innovation.

Lay, founder of the global biotech company BioLegend, brings invaluable experience as an industry leader and innovator. 

Clarivate’s annual, global list represents researchers who have demonstrated significant and broad influence in their field of research.